Michael C. Cameron

Michael Cameron practices at Cameron Dermatology in New York, New York.

Michael Cameron's NPI, 1912391186, was assigned on March 25, 2015. Michael Cameron graduated from University of South Florida Morsani College of Medicine in 2015. Michael Cameron holds New York license 297241.

Michael Cameron's primary practice is Cameron Dermatology, at 200 Amsterdam Ave, New York, NY 10023-5005. The practice phone is (212) 920-6597.

Michael Cameron's primary practice is Cameron Dermatology in New York, New York. The medical group on file is Cameron Dermatology. Dmand AI also links Michael Cameron to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Cameron practices. Vendor and product names are available with a free account.

Dermatology is Michael Cameron's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Michael Cameron is licensed in New York.

CMS data shows 7,471 Medicare services from Michael Cameron across 20 procedure codes in 2024, for 537 Medicare patients. Medicare paid $148,458 for them. Every service was in an office.

CMS counts 537 Medicare patients who saw Michael Cameron in 2024. The largest group is 65 to 74, with 243 patients. 75% of them have high cholesterol, and 55% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Michael Cameron's median patient age at 44, with 43% women.

In 2024, Michael Cameron wrote 722 Medicare Part D claims for 294 patients. 84% of them were for generic drugs. CMS names the drug for 557 of them, across 14 drugs with 11 or more claims each, at $167,624 in total drug cost. In 2023, CMS named 687 claims across 18 drugs.

Michael Cameron accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 185 procedures of removal of skin lesions by Michael Cameron, more than 79% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Michael Cameron, published from 2016 to 2024. 2018 was the busiest year, with 4. The most frequent topics are Dermatitis, Atopic, Double-Blind Method and Skin Neoplasms. Michael Cameron has published most often in J Am Acad Dermatol. Michael Cameron's most frequent co-authors are Hernan Valdez, MD, Ramin Fathi, MD and Theodore James Alkousakis, MD.

CMS Open Payments shows 3,517 general payments to Michael Cameron from 36 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Abbvie Inc. paid the most, $570,220. It also lists 17 research payments totaling $32,090 from 2021 to 2025, naming 1 clinical trial.

Michael Cameron graduated from University of South Florida Morsani College of Medicine in 2015.